Zobrazeno 1 - 10
of 29
pro vyhledávání: '"M S Osato"'
Autor:
Rhonda A. Cole, Robert M. Genta, Karen L. Woods, I E Gurer, M S Osato, D D Rossi, Hoda M. Malaty, B S Anand
Publikováno v:
Gastrointestinal Endoscopy. 49:177-183
Background OEM/ODM Canvas Style Stainless Steel Adjustable Ice Skate .Color Coating Aluminum/Aluminium Coil Plate for Building Material,Magnet Strip Tape Extruder Machine/Magnetic Production Line, size, shape,Textured ABS/TPU Sheet for Automotive Int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd0106c4fc92e03078617d9f81db383
https://doi.org/10.1016/s0016-5107(99)70483-9
https://doi.org/10.1016/s0016-5107(99)70483-9
Autor:
D.Y. Graham, D Shortridge, G. G. Stone, K Spakovsky, Rita Reddy, J Versalovic, M S Osato, Maria Pina Dore, R K Flamm, S. K. Tanaka
Publikováno v:
Journal of Antimicrobial Chemotherapy. 40:283-286
Fifty-four of 59 (91.5%) clarithromycin-resistant isolates of Helicobacter pylori from different patients possessed either the A2143G (formerly A2058G) or the A2144G (formerly A2059G) mutation in the gene encoding 23S rRNA. The A2143G mutation was si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5251d90d10823419740bc249c83a874d
https://doi.org/10.1093/jac/40.2.283
https://doi.org/10.1093/jac/40.2.283
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 36(6)
Quadruple therapy provided inadequate eradication rate when given twice-a-day at breakfast and evening meals.To test twice daily (mid-day and evening) quadruple therapy for Helicobacter pylori eradication.This was a single-centre pilot study in which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17b746099119e8abb7219f14e6b72d1e
https://pubmed.ncbi.nlm.nih.gov/15248375
https://pubmed.ncbi.nlm.nih.gov/15248375
Publikováno v:
Alimentary pharmacologytherapeutics. 17(10)
To compare H2-receptor antagonists and proton pump inhibitors as adjuvants to triple therapy for Helicobacter pylori eradication.H. pylori-infected patients with peptic ulcer were randomized to receive either 300 mg nizatidine or 30 mg lansoprazole p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e6da6d9183b0387946fcd98908a15e2
https://pubmed.ncbi.nlm.nih.gov/12755836
https://pubmed.ncbi.nlm.nih.gov/12755836
Publikováno v:
Alimentary pharmacologytherapeutics. 17(2)
Antisecretory therapy may exacerbate Helicobacter pylori corpus gastritis. The rate and mechanism(s) remain unknown.To investigate the early events in proton pump inhibitor therapy on antral and corpus H. pylori gastritis.Nine H. pylori-infected volu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dac41c01fc4a0552ea832001a3c07c45
https://pubmed.ncbi.nlm.nih.gov/12534403
https://pubmed.ncbi.nlm.nih.gov/12534403
Publikováno v:
Journal of applied microbiology. 93(6)
Aims: To evaluate a traditional yoghurt used as folk medicine for its ability to kill Helicobacter pylori in vitro. Methods and Results: Micro-organisms from the yoghurt were identified and tested in different food substrates for their effects on H.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8794e8b1f8f520af685f638b22eb9c
https://pubmed.ncbi.nlm.nih.gov/12452966
https://pubmed.ncbi.nlm.nih.gov/12452966
Publikováno v:
Alimentary pharmacologytherapeutics. 15(11)
In a previous study, the use of a citric acid test meal produced a rapid dose-dependent increase in urease activity that was significantly greater than that resulting from a pudding meal, ascorbic acid or sodium citrate. The mechanism was hypothesize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae94c6746300d8361b873dd54a624a2c
https://pubmed.ncbi.nlm.nih.gov/11683690
https://pubmed.ncbi.nlm.nih.gov/11683690
Publikováno v:
Alimentary pharmacologytherapeutics. 15(4)
Emergence of antibiotic resistant Helicobacter pylori has necessitated the identification of alternate therapies for the treatment of this infection.To assess the in vitro efficacy of two investigational agents: DMG-MINO CL 344 (a N,N-dimethylglycyla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::caa59cbbb04c63dd63634851c6ff5d97
https://pubmed.ncbi.nlm.nih.gov/11284777
https://pubmed.ncbi.nlm.nih.gov/11284777
Publikováno v:
Alimentary pharmacologytherapeutics. 15(4)
Antibiotic resistance has increasingly been recognized as the major cause of treatment failure for Helicobacter pylori infection. New therapies for patients with metronidazole- or clarithromycin-resistant H. pylori are needed.To investigate the role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e32abeb80d42119be6ce43156806d613
https://pubmed.ncbi.nlm.nih.gov/11284780
https://pubmed.ncbi.nlm.nih.gov/11284780
Autor:
Dong H. Kwon, F. A. K. El-Zaatari, David Y. Graham, M. S. Osato, Jae J. Kim, Miae Lee, Jong G. Kim
Publikováno v:
Antimicrobial agents and chemotherapy. 45(1)
The prevalence of furazolidone, nitrofurantoin, and metronidazole resistance among Helicobacter pylori strains was assessed with 431 clinical isolates. Fifty-two percent were metronidazole resistant, compared to 2% (7 of 431) with resistance to furaz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c4e079c078d3357e78532e2758bd2e
https://pubmed.ncbi.nlm.nih.gov/11120984
https://pubmed.ncbi.nlm.nih.gov/11120984